FI120259B - Menetelmä epoksidin valmistamiseksi - Google Patents

Menetelmä epoksidin valmistamiseksi Download PDF

Info

Publication number
FI120259B
FI120259B FI963452A FI963452A FI120259B FI 120259 B FI120259 B FI 120259B FI 963452 A FI963452 A FI 963452A FI 963452 A FI963452 A FI 963452A FI 120259 B FI120259 B FI 120259B
Authority
FI
Finland
Prior art keywords
allyl
formula
acetonide
epoxide
equivalent
Prior art date
Application number
FI963452A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963452A (fi
FI963452A0 (fi
Inventor
David Askin
Kan K Eng
Peter E Maligres
Paul J Reider
Kai Rossen
Ralph P Volante
Veena Upadhyay
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22764868&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI120259(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI963452A publication Critical patent/FI963452A/fi
Publication of FI963452A0 publication Critical patent/FI963452A0/fi
Application granted granted Critical
Publication of FI120259B publication Critical patent/FI120259B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI963452A 1994-03-04 1996-09-03 Menetelmä epoksidin valmistamiseksi FI120259B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20607494A 1994-03-04 1994-03-04
US20607494 1994-03-04
US9502347 1995-02-27
PCT/US1995/002347 WO1995023797A1 (en) 1994-03-04 1995-02-27 Process for making an epoxide

Publications (3)

Publication Number Publication Date
FI963452A FI963452A (fi) 1996-09-03
FI963452A0 FI963452A0 (fi) 1996-09-03
FI120259B true FI120259B (fi) 2009-08-31

Family

ID=22764868

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963452A FI120259B (fi) 1994-03-04 1996-09-03 Menetelmä epoksidin valmistamiseksi

Country Status (25)

Country Link
EP (1) EP0748319B1 (ro)
JP (1) JP3871705B2 (ro)
KR (1) KR100387741B1 (ro)
CN (1) CN1066728C (ro)
AT (1) ATE210662T1 (ro)
AU (1) AU690231B2 (ro)
BR (1) BR9506977A (ro)
CA (1) CA2183976C (ro)
CZ (1) CZ291816B6 (ro)
DE (1) DE69524578T2 (ro)
DK (1) DK0748319T3 (ro)
ES (1) ES2167419T3 (ro)
FI (1) FI120259B (ro)
HR (1) HRP950096B1 (ro)
HU (1) HU222750B1 (ro)
MX (1) MX9603871A (ro)
NZ (1) NZ281866A (ro)
PT (1) PT748319E (ro)
RO (1) RO117696B1 (ro)
RU (1) RU2137769C1 (ro)
SK (1) SK283067B6 (ro)
TW (1) TW380137B (ro)
UA (1) UA45968C2 (ro)
WO (1) WO1995023797A1 (ro)
YU (1) YU49010B (ro)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728840A (en) * 1994-03-04 1998-03-17 Merck & Co., Inc. Process for making an epoxide
TW415948B (en) * 1995-10-30 2000-12-21 Merck & Co Inc Process for synthesizing epoxide and halohydrin
US5981759A (en) * 1997-06-20 1999-11-09 Merck & Co., Inc. Process for indinavir intermediate
PT2623113T (pt) 2005-11-09 2017-07-14 Onyx Therapeutics Inc Compostos para inibição de enzimas
SI2041158T1 (sl) 2006-06-19 2013-09-30 Onyx Therapeutics, Inc. Peptidni epoksiketoni za inhibicijo proteasomov
TWI501773B (zh) 2007-10-04 2015-10-01 Onyx Therapeutics Inc 結晶肽環氧酮蛋白酶抑制劑以及胺基酸酮環氧化物之合成
BRPI0919668A2 (pt) 2008-10-21 2018-05-29 Onyx Therapeutics, Inc. terapia de combinação com epóxi-cetonas de peptídeo
AR075899A1 (es) 2009-03-20 2011-05-04 Onyx Therapeutics Inc Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
US8853147B2 (en) 2009-11-13 2014-10-07 Onyx Therapeutics, Inc. Use of peptide epoxyketones for metastasis suppression
MX2012010017A (es) 2010-03-01 2012-10-01 Onyx Therapeutics Inc Compuestos de para la inhibicion de inmunoproteasomas.
CN103025730A (zh) * 2010-04-30 2013-04-03 印第安纳大学研究及科技有限公司 制备利奈唑胺的方法
WO2014011695A2 (en) 2012-07-09 2014-01-16 Onyx Therapeutics, Inc. Prodrugs of peptide epoxy ketone protease inhibitors
CN104692987B (zh) * 2015-01-22 2017-05-17 北京大学 卤代醇及其衍生物的廉价高效合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072237A1 (en) * 1991-07-02 1993-01-03 Merck & Co., Inc. Stereoselective production of hydroxyamide compounds from chiral –-amino epoxides
CA2081970C (en) * 1991-11-08 1997-07-08 Joseph P. Vacca Hiv protease inhibitors useful for the treatment of aids

Also Published As

Publication number Publication date
DK0748319T3 (da) 2002-03-18
ATE210662T1 (de) 2001-12-15
FI963452A (fi) 1996-09-03
CA2183976C (en) 2005-02-01
UA45968C2 (uk) 2002-05-15
EP0748319B1 (en) 2001-12-12
BR9506977A (pt) 1997-09-02
SK112296A3 (en) 1997-02-05
SK283067B6 (sk) 2003-02-04
RU2137769C1 (ru) 1999-09-20
DE69524578T2 (de) 2002-07-18
ES2167419T3 (es) 2002-05-16
CZ254396A3 (en) 1997-01-15
YU49010B (sh) 2003-04-30
HU9602412D0 (en) 1996-11-28
RO117696B1 (ro) 2002-06-28
WO1995023797A1 (en) 1995-09-08
HRP950096A2 (en) 1997-06-30
CN1066728C (zh) 2001-06-06
HUT75611A (en) 1997-05-28
CN1146768A (zh) 1997-04-02
EP0748319A1 (en) 1996-12-18
AU690231B2 (en) 1998-04-23
MX9603871A (es) 1997-07-31
YU14595A (sh) 1997-12-05
FI963452A0 (fi) 1996-09-03
PT748319E (pt) 2002-05-31
CA2183976A1 (en) 1995-09-08
HRP950096B1 (en) 2002-06-30
JPH09509929A (ja) 1997-10-07
JP3871705B2 (ja) 2007-01-24
CZ291816B6 (cs) 2003-06-18
KR100387741B1 (ko) 2003-10-04
KR970701714A (ko) 1997-04-12
AU1882895A (en) 1995-09-18
NZ281866A (en) 1998-05-27
DE69524578D1 (de) 2002-01-24
HU222750B1 (hu) 2003-09-29
TW380137B (en) 2000-01-21

Similar Documents

Publication Publication Date Title
CN108718527B (zh) 用于制备化合物的方法
US20120283434A1 (en) Process for the preparation of rivaroxaban and intermediates thereof
FI120259B (fi) Menetelmä epoksidin valmistamiseksi
EP3152191B1 (en) Improved process for making duocarmycin prodrugs
WO2022214645A1 (en) Processes and intermediates for the preparation of relugolix
AU676079B2 (en) Process for making HIV protease inhibitors
EP0708763B1 (en) Process for making hiv protease inhibitors
AU681499B2 (en) Regiospecific process to make cis-1-amino-2-alkanol from epoxide
DE69813886T2 (de) Naphthalin derivate
US5728840A (en) Process for making an epoxide
CZ266196A3 (cs) Regioselektivní způsob výroby cis-1-amino-2-indanolu
Kato et al. Synthesis of 6‐amino‐1‐benzyl‐4‐methylhexahydro‐1H‐1, 4‐diazepine
JP2014125458A (ja) 光学活性ベンズアミド誘導体の製造方法
CA2167183C (en) Process for making hiv protease inhibitors
KR100393744B1 (ko) 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온의 제조방법
KR20020081771A (ko) 신규의 아지리딘 유도체 및 그 제조방법
ITMI20011435A1 (it) Procedimento per la produzione di benzossazine e nuove benzossasine

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120259

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

Free format text: MERCK SHARP & DOHME CORP.

MM Patent lapsed